PI
SPPI

PineBridge Investments’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

PineBridge Investments’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-76,707
Closed -$279K – 1061
2019
Q4 		$279K Sell
76,707
-41,169
-35% -$333K ﹤0.01% 866
2019
Q3 		$978K Buy
117,876
+5,193
+5% +$42K 0.02% 765
2019
Q2 		$971K Buy
112,683
+85,608
+316% +$766K 0.02% 699
2019
Q1 		$289K Sell
27,075
-3,290
-11% -$35.2K 0.01% 796
2018
Q4 		$266K Sell
30,365
-32,180
-51% -$410K 0.01% 812
2018
Q3 		$1.05M Sell
62,545
-2,368
-4% -$51.2K 0.02% 582
2018
Q2 		$1.36M Sell
64,913
-2,917
-4% -$54K 0.03% 518
2018
Q1 		$1.09M Sell
67,830
-75,882
-53% -$1.5M 0.03% 564
2017
Q4 		$2.72M Buy
143,712
+19,886
+16% +$360K 0.07% 255
2017
Q3 		$1.74M Sell
123,826
-3,682
-3% -$33.3K 0.04% 341
2017
Q2 		$950K Buy
127,508
+29,483
+30% +$193K 0.02% 517
2017
Q1 		$637K Buy
98,025
+31,866
+48% +$178K 0.02% 612
2016
Q4 		$293K Buy
66,159
+57,184
+637% +$240K 0.01% 767
2016
Q3 		$42K Buy
8,975
+1,249
+16% +$7.4K ﹤0.01% 992
2016
Q2 		$51K Buy
7,726
+762
+11% +$5.38K ﹤0.01% 948
2016
Q1 		$45K Sell
6,964
-990
-12% -$5.08K ﹤0.01% 941
2015
Q4 		$48K Buy
7,954
+267
+3% +$1.53K ﹤0.01% 946
2015
Q3 		$46K Buy
7,687
+718
+10% +$4.98K ﹤0.01% 957
2015
Q2 		$47K Sell
6,969
-8,062
-54% -$51.2K ﹤0.01% 963
2015
Q1 		$91K Buy
15,031
+1,325
+10% +$8.81K ﹤0.01% 925
2014
Q4 		$95K Buy
13,706
+1,566
+13% +$11.5K ﹤0.01% 923
2014
Q3 		$98K Buy
12,140
+3,375
+39% +$26.4K ﹤0.01% 862
2014
Q2 		$71K Sell
8,765
-4,260
-33% -$32.3K ﹤0.01% 875
2014
Q1 		$102K Sell
13,025
-1,299
-9% -$11K ﹤0.01% 931
2013
Q4 		$127K Buy
14,324
+8,269
+137% +$73.9K ﹤0.01% 919
2013
Q3 		$51K Buy
6,055
+212
+4% +$1.72K ﹤0.01% 928
2013
Q2 		$43K Buy
+5,843
New +$44.8K ﹤0.01% 962

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PineBridge Investments's SPPI Position: Q1 2020 in Review

PineBridge Investments sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 76,707 shares — an estimated $279K sold.

PineBridge Investments first reported a position in SPPI in Q2 2013 and held it in 27 quarters. The position peaked at $2.72M in Q4 2017. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • PineBridge Investments reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • PineBridge Investments sold 76,707 Spectrum Pharmaceuticals Inc shares in Q1 2020, an estimated $279K.
  • PineBridge Investments first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 27 quarters.
  • PineBridge Investments's Spectrum Pharmaceuticals Inc position peaked at $2.72M in Q4 2017.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.